Pharmacopeia Inc: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	51
ISBN Number	not applicable
Product Code	DAT09419

Price

£265.00
approximately: $468 | €336

PRINT £265 ($468 | €336)

Order above formats by FAX

Summary

Introduction

Pharmacopeia is a clinical development stage company engaged in the discovery and development of small molecule therapeutics primarily to address significant medical needs. Using proprietary technologies and processes, Pharmacopeia discovers and develops novel drug candidates to advance internally, as well as with strategic partners.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Pharmacopeia is a biopharmaceutical company developing small molecule therapeutics to treat diseases such as rheumatoid arthritis, multiple sclerosis, and psoriasis. The company has a number of product candidates in internal as well as collaboration pipeline.

During 2002-2006, the company recorded all of its revenues under collaborative agreements and its total revenues decreased at a CAGR of 13%, from $29 million to $17 million. This represents an absolute decline of -$12 million during the same period primarily due to the expiration of collaborative agreements.

The company is forecasted to receive 100% of its revenues between 2006 and 2010 from its collaborations, which is estimated to grow at a CAGR of 22%, from $17 million to $38 million in 2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Pharmacopeia - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 1: Pharmacopeia - Key Facts
- Table 2: Pharmacopeia - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Pharmacopeia - Key Events Impacting Share Price Performance
- Table 4: Pharmacopeia - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Pharmacopeia - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 6: Pharmacopeia - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Pharmacopeia - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Pharmacopeia - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 9: Pharmacopeia - in-house Pipeline Products
- Table 10: Pharmacopeia- Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 11: Pharmacopeia - Key Competitors
- Table 12: Pharmacopeia - Key Suppliers
- Table 13: Pharmacopeia - Key Clients
- Table 14: Pharmacopeia - Key Shareholders
- Table 15: Pharmacopeia - SWOT Analysis Summary
- Table 16: Pharmacopeia - Value Chain Analysis
- Table 17: Pharmacopeia - Scorecard
- Table 18: Pharmacopeia - Key Employees
- Table 19: Pharmacopeia - Financial and Operational Overview